Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

ITDA67,27760,285199,107180,580Equity-based compensation6,1264,84417,61012,691Acquisition accounting adjustments-12-205Transaction costs5,689-6,024-Facilities consolidation costs1981,1487111,551Acquisition-related costs1,4481,4164,2373,442Tax receivable agreements change in estimate3211,162547(318)Contingent consideration adjustments(4,398)(2,370)(8,036)(4,140)EBITDA Adjustments9,3846,21221,09313,431Adjusted EBITDA$
76,661$
,497$
220,200$
94,011Emdeon Inc.Reconciliation of GAAP Net Income to Adjusted Net Income(unaudited and amounts in thousands)For the Three MonthsFor the Nine MonthsEnded September 30, Ended September 30, 2011201020112010Net income $
,273$
,627$
22,777$
8,141Income tax provision8,6017,49821,69627,650EBITDA Adjustments9,3846,21221,09313,431Non-cash interest expense2,4165,5317,57014,749Depreciation and amortization resulting from acquisition method adjustments27,33620,31880,21259,458Adjusted net income before income taxes54,01046,186153,348133,429Normalized income tax provision21,33418,24360,57252,704Adjusted Net Income$
32,676$
27,943$
92,776$
80,725Emdeon Inc.Reconciliation of GAAP Net Income Per Diluted Share of Class A Common Stock to Adjusted Net Income Per Fully Diluted Share(1)(unaudited)For the Three MonthsFor the Nine MonthsEnded September 30, Ended September 30, 2011201020112010Net income per diluted share of Class A common stock$
.04$
.04$
.15$
.11Impact of assuming full dilution of all outstanding equity instruments for the period0.000.010.030.03Adjustments on a per share basis:Income tax provision0.070.060.180.23EBITDA Adjustments0.080.050.170.11Non-cash interest expense0.020.050.060.12Depreciation and amortization resulting from acquisition method adjustments0.220.170.650.49Adjusted net income before income taxes0.430.381.241.09Normalized income tax provision0.17
'/>"/>
SOURCE Emdeon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) ... "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with the ... provides an update for shareholders detailing why a "YES" vote ... Dear Shareholders, As we reflect upon the ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Data Presented at the 11th International Myeloma Workshop ... 29, 2007,/PRNewswire/ -- The International Myeloma Foundation (IMF) ... myeloma patients, families, researchers and physicians -- today,said ... Workshop in Greece demonstrate improved survival for a ...
... 2007 - The drug most,commonly used to arrest ... common treatment to cause mild to serious side,effects ... researchers at,Lucile Packard Children's Hospital and Stanford University ... effectiveness,of the two drugs appears similar, physicians should ...
Cached Medicine Technology:The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 2The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 3The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 4Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 2Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 3Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 4
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
(Date:12/26/2014)... Dallas, TX (PRWEB) December 26, 2014 The ... covered in this report. In 2013, GlobalData’s forecast estimates that ... the largest CRC market due to the high incidence of ... compared with the 5EU, Japan, and China. Increased sales of ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Beijing: A human case of bird flu was confirmed in ... farmer in east China's Anhui province had contracted the H5N1 ... developed fever and pneumonia Dec 10 and was discharged from ... ,The Chinese Centre for Disease Control and Prevention ...
... red meat and foods rich in heme iron may increase ... Qi , lead researcher of the study says, patients with ... like chicken liver, clams and oysters. ,Dr Qi ... observe that metabolic abnormalities related to diabetes may magnify the ...
... actually foretell the risk of complications in patients due ... who suffer severe cardiac problems, and a timely diagnosis ... ,A study published today, claims that abnormal ... inherent heart disease risk, evidently eight times more pronounced ...
... cause of end-stage kidney disease worldwide, an illness that ... for survival. // ,A research team at Wake ... Heidelberg has proven that a gene protects some people ... renal disease." ,The carnosinase 1 gene, located ...
... of positive attitude are happy and confident in caring ... Children's Hospital of Philadelphia conducted a survey of several ... showed that, nurses who were positive and confident about ... in palliative care. The study appears in the January ...
... can effectively help us fight cancer. Tumours can be ... spicy and hot sensation. ,They also feel that ... University of Nottingham scientists claim that this chemical targets the ... are used in the treatment of psoriasis and muscle strains ...
Cached Medicine News:Health News:A Gene Associated With Severe Kidney Failure in Diabetes Found 2Health News:Positively Charged Nurses, Best in Nursing Dying Children 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: